Razavi Journal of Medicine

Razavi Journal of Medicine

Prevalence of Adenomyosis in Hysterectomy Specimens from Patients with Benign Gynecological Conditions

Articles in Press

Document Type : Original Article

Authors
Taraneh Mohajeri 1
Sajad Moosavi 2
Zahra Mostafavian 3
1 Department of Gynecology, Faculty of Medicine, Mashhad Medical Sciences, Islamic Azad University, Mashhad, Iran.
2 . Innovative Medical Research Center, Faculty of Medicine, Mashhad Medical Sciences, Islamic Azad University, Mashhad, Iran.
3 Department of Community Medicine, Faculty of Medicine, Mashhad Medical Sciences, Islamic Azad University, Mashhad, Iran.
10.30483/rjm.2026.254664.1436
Abstract
Background: Adenomyosis is defined by the ectopic presence of endometrial tissue within the myometrium. The reported histopathological prevalence in hysterectomy specimens varies substantially (8.8–61.5%), and associated risk factors remain a subject of debate.

Objectives: This study aimed to determine the prevalence of adenomyosis in hysterectomy specimens obtained for benign gynecological indications and to evaluate its association with key demographic and clinical variables.

Methods: This cross-sectional investigation (2023–2025) consecutively enrolled 99 women who underwent hysterectomy for benign conditions at hospitals affiliated with Mashhad Medical Sciences, Islamic Azad University. Patients with gynecological malignancies or incomplete medical records were excluded. Demographic and obstetric data, including age, body mass index (BMI), educational attainment, gravidity, parity, mode of delivery, and history of abortion, were systematically recorded. Adenomyosis was diagnosed through histopathological examination. Following assessment of normality using the Shapiro–Wilk test, continuous variables were compared using the independent-samples t-test, and categorical variables were analyzed using the chi-square test (statistical significance set at p < 0.05).

Results: Adenomyosis was histologically confirmed in 36 women (36.4%). The mean age of the cohort was 55.3 ± 10.4 years, and the mean BMI was 27.7 ± 3.7 kg/m². Women diagnosed with adenomyosis exhibited a significantly higher mean BMI compared to those without the condition (30.1 ± 3.0 vs. 26.3 ± 3.4 kg/m²; p < 0.001). In the categorical analysis, adenomyosis was absent in all participants with a normal BMI (<25 kg/m²) but was identified in 38.3% of overweight women and 58.1% of obese women (p < 0.001). No statistically significant associations were observed between adenomyosis and age, gravidity, parity, mode of delivery, history of abortion, or educational level.

Conclusion: Adenomyosis was present in over one-third of hysterectomy specimens obtained for benign indications. Elevated BMI emerged as the sole significant risk factor associated with the condition, highlighting overweight and obesity as potentially modifiable contributors to adenomyosis pathogenesis.
Keywords
Adenomyosis
Body Mass Index
Hysterectomy
Benign Gynecologic Diseases
Risk Factors

Subjects

Acknowledgements: We extend our sincere gratitude to all patients who participated in this study. We also wish to thank the staff and experts of the Research Centre of Mashhad Medical Sciences, Islamic Azad University, particularly Dr. Tooraj Zandbaf, Vice President for Research, for their invaluable technical support and assistance during the preparation of this manuscript. Finally, we appreciate the contributions of all individuals who supported the completion of this research.

Availability of data and material: All data used in this study are included in the results of this article.

Conflicts of interests: The authors declare no conflicts of interest.

Ethical Considerations: This study was reviewed and approved by the Research Ethics Committee of Mashhad Islamic Azad University of Medical Sciences (Approval Code: IR.IAU.MSHD.REC.1402.190). Written informed consent was obtained from all individual participants included in the study. All procedures performed were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments. Patient data confidentiality was strictly maintained, and participants retained the right to withdraw from the study at any time without consequence. 

Financial disclosure: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author contributions: Conceptualization: Taraneh Mohajeri (TM); Methodology and Formal analysis: Zahra Mostafavian (ZM), Sajad Moosavi (SM); Investigation and Data curation: Sajad Moosavi (SM); Writing – Original draft: Sajad Moosavi (SM); Writing – Review & Editing: Taraneh Mohajeri (TM), Sajad Moosavi (SM). All authors have read and approved the final version of the manuscript and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Policy: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/

1. Novellas S, Chassang M, Delotte J, Toullalan O, Chevallier A, Bouaziz J, et al. MRI characteristics of the uterine junctional zone: from normal to the diagnosis of adenomyosis. American Journal of Roentgenology. 2011;196(5):1206-13.
https://doi.org/10.2214/AJR.10.4877
PMid:21512093
 
2. Devlieger R, D'Hooghe T, Timmerman D. Uterine adenomyosis in the infertility clinic. Human Reproduction Update. 2003;9(2):139-47.
https://doi.org/10.1093/humupd/dmg010
PMid:12751776
 
3. Uduwela A, Perera M, Aiqing L, Fraser I. Endometrial-myometrial interface: relationship to adenomyosis and changes in pregnancy. Obstetrical & gynecological survey. 2000;55(6):390-400.
https://doi.org/10.1097/00006254-200006000-00025
PMid:10841317
 
4. Bulun SE, Yildiz S, Adli M, Wei J-J. Adenomyosis pathogenesis: insights from next-generation sequencing. Human reproduction update. 2021;27(6):1086-97.
https://doi.org/10.1093/humupd/dmab017
PMid:34131719 PMCid:PMC8543024
 
5. Khan KN, Fujishita A, Mori T. Pathogenesis of human adenomyosis: current understanding and its association with infertility. Journal of clinical medicine. 2022;11(14):4057.
https://doi.org/10.3390/jcm11144057
PMid:35887822 PMCid:PMC9316454
 
6. Taran F, Stewart E, Brucker S. Adenomyosis: epidemiology, risk factors, clinical phenotype and surgical and interventional alternatives to hysterectomy. Geburtshilfe und Frauenheilkunde. 2013;73(09):924-31.
https://doi.org/10.1055/s-0033-1350840
PMid:24771944 PMCid:PMC3859152
 
7. Gordts S, Grimbizis G, Campo R. Symptoms and classification of uterine adenomyosis, including the place of hysteroscopy in diagnosis. Fertility and sterility. 2018;109(3):380-8. e1.
https://doi.org/10.1016/j.fertnstert.2018.01.006
PMid:29566850 PMCid:PMC10493363
 
8. Rathod K, Magro M, Shehzad S. Adenomyosis: Current knowledge, Recent Advances and Future Perspective. Gynecol Reprod Health. 2023; 7 (3): 1-8.
https://doi.org/10.33425/2639-9342.1223
 
9. Taylor MA, Croudace TJ, McBride M, Muir FE. Women's experiences of the diagnostic journey in uterine adenomyosis: a scoping review protocol. BMJ open. 2024;14(1):e075316.
https://doi.org/10.1136/bmjopen-2023-075316
PMid:38238180 PMCid:PMC10806690
 
10. Sharara FI, Kheil MH, Feki A, Rahman S, Klebanoff JS, Ayoubi JM, et al. Current and prospective treatment of adenomyosis. Journal of clinical medicine. 2021;10(15):3410.
https://doi.org/10.3390/jcm10153410
PMid:34362193 PMCid:PMC8348135
 
11. Parazzini F, Mais V, Cipriani S, Busacca M, Venturini P. Determinants of adenomyosis in women who underwent hysterectomy for benign gynecological conditions: results from a prospective multicentric study in Italy. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2009;143(2):103-6.
https://doi.org/10.1016/j.ejogrb.2008.12.010
PMid:19232812
 
12. Li J, Wei J, Chen S, Wang X, Chen J, Zeng D, et al. Prevalence and risk factors for chronic endometritis in patients with adenomyosis and infertility: a retrospective cohort study. BMC Women's Health. 2024;24(1):403.
https://doi.org/10.1186/s12905-024-03245-2
PMid:39014375 PMCid:PMC11251133
 
13. Zaid SMO, Thabet MAB. Histopathological findings in hysterectomy specimens: a retrospective study. Middle East J Intern Med. 2017;10:1-8.
https://doi.org/10.5742/MEIM.2017.93046
 
14. Giorgi M, Raimondo D, Pacifici M, Bartiromo L, Candiani M, Fedele F, et al. Adenomyosis among patients undergoing postpartum hysterectomy for uncontrollable uterine bleeding: A multicenter, observational, retrospective, cohort study on histologically‐based prevalence and clinical characteristics. International Journal of Gynecology & Obstetrics. 2024;166(2):849-58.
https://doi.org/10.1002/ijgo.15452
PMid:38494900
 
15. Krentel H, De Wilde RL. Prevalence of adenomyosis in women undergoing hysterectomy for abnormal uterine bleeding, pelvic pain or uterine prolapse-A retrospective cohort study. Annals of Medicine and Surgery. 2022;78:103809.
https://doi.org/10.1016/j.amsu.2022.103809
PMid:35734686 PMCid:PMC9206934
 
16. Goti R. Histopathological Spectrum of Lesions in Hysterectomy Specimens: A Five-Year Retrospective Study. International Journal of Life Sciences, Biotechnology and Pharma Research.14(4):93-6.
 
17. Bai R, Ashraf A, Shoeb S, Hussain Z, Tabassum F, Tabassum F. Etiological Factors Associated With Abnormal Uterine Bleeding Among Adult Women Presenting to Tertiary Healthcare Settings. Cureus. 2025;17(7).
https://doi.org/10.7759/cureus.88019
 
18. Mishra I, Melo P, Easter C, Sephton V, Dhillon‐Smith R, Coomarasamy A. Prevalence of adenomyosis in women with subfertility: systematic review and meta‐analysis. Ultrasound in Obstetrics & Gynecology. 2023;62(1):23-41.
https://doi.org/10.1002/uog.26159
PMid:36647238
 
Razavi Journal of Medicine

Articles in Press, Accepted Manuscript
Available Online from 04 May 2026